II
ELV icon

IFM Investors’s Elevance Health ELV Stock Holding History

IFM Investors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8M Buy
51,315
+2,382
+5% +$883K 0.13% 128
2026
Q1 		$14.3M Buy
48,933
+914
+2% +$300K 0.12% 163
2025
Q4 		$16.8M Sell
48,019
-435
-0.9% -$147K 0.14% 125
2025
Q3 		$15.4M Buy
48,454
+100
+0.2% +$31.1K 0.14% 134
2025
Q2 		$18.8M Buy
48,354
+1,197
+3% +$481K 0.18% 107
2025
Q1 		$20.5M Buy
47,157
+524
+1% +$210K 0.22% 89
2024
Q4 		$17.2M Sell
46,633
-3,499
-7% -$1.46M 0.17% 103
2024
Q3 		$26.1M Buy
50,132
+978
+2% +$522K 0.25% 72
2024
Q2 		$26.6M Buy
49,154
+106
+0.2% +$56K 0.27% 69
2024
Q1 		$25.4M Sell
49,048
-380
-0.8% -$189K 0.28% 67
2023
Q4 		$23.3M Sell
49,428
-487
-1% -$225K 0.28% 69
2023
Q3 		$21.7M Buy
49,915
+1,556
+3% +$706K 0.29% 68
2023
Q2 		$21.5M Buy
48,359
+2,161
+5% +$997K 0.28% 72
2023
Q1 		$21.2M Buy
46,198
+1,133
+3% +$539K 0.32% 62
2022
Q4 		$23.1M Buy
45,065
+2,940
+7% +$1.49M 0.39% 51
2022
Q3 		$19.1M Buy
42,125
+842
+2% +$403K 0.35% 53
2022
Q2 		$19.9M Buy
41,283
+1,937
+5% +$958K 0.35% 58
2022
Q1 		$19.3M Buy
39,346
+5,841
+17% +$2.67M 0.3% 69
2021
Q4 		$15.5M Sell
33,505
-315
-0.9% -$133K 0.28% 71
2021
Q3 		$12.6M Buy
33,820
+1,443
+4% +$548K 0.26% 77
2021
Q2 		$12.4M Buy
32,377
+5,196
+19% +$1.99M 0.25% 82
2021
Q1 		$9.76M Buy
27,181
+2,856
+12% +$918K 0.26% 78
2020
Q4 		$7.81M Buy
24,325
+3,567
+17% +$1.09M 0.25% 81
2020
Q3 		$5.58M Buy
20,758
+2,153
+12% +$579K 0.23% 83
2020
Q2 		$4.89M Sell
18,605
-7,873
-30% -$2.1M 0.25% 76
2020
Q1 		$6.11M Sell
26,478
-975
-4% -$266K 0.27% 78
2019
Q4 		$8.29M Sell
27,453
-194
-0.7% -$53.4K 0.29% 71
2019
Q3 		$6.64M Buy
27,647
+9,584
+53% +$2.63M 0.25% 87
2019
Q2 		$5.1M Buy
18,063
+1,317
+8% +$360K 0.29% 69
2019
Q1 		$4.81M Buy
16,746
+1,838
+12% +$532K 0.31% 70
2018
Q4 		$3.92M Buy
14,908
+1,525
+11% +$419K 0.32% 69
2018
Q3 		$3.67M Buy
13,383
+1,798
+16% +$467K 0.28% 76
2018
Q2 		$2.76M Buy
11,585
+3,594
+45% +$832K 0.26% 82
2018
Q1 		$1.76M Buy
7,991
+648
+9% +$152K 0.25% 90
2017
Q4 		$1.65M Sell
7,343
-79
-1% -$16.8K 0.26% 87
2017
Q3 		$1.41M Buy
7,422
+153
+2% +$29.1K 0.24% 96
2017
Q2 		$1.37M Buy
7,269
+1,975
+37% +$355K 0.25% 98
2017
Q1 		$876K Buy
5,294
+1,934
+58% +$308K 0.22% 108
2016
Q4 		$483K Buy
+3,360
New +$450K 0.23% 118

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

IFM Investors's ELV Position: Q2 2026 in Review

IFM Investors increased its Elevance Health (ELV) stake by 4.9% in Q2 2026, buying an estimated $883K and bringing the position to 51,315 shares worth $19.8M. The position accounts for 0.13% of the portfolio, ranked #128.

IFM Investors first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. The position peaked at $26.6M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • IFM Investors held 51,315 shares of Elevance Health worth $19.8M as of Q2 2026.
  • IFM Investors bought 2,382 Elevance Health shares in Q2 2026, an estimated $883K.
  • Elevance Health made up 0.13% of IFM Investors's portfolio in Q2 2026, its #128 holding.
  • IFM Investors first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's Elevance Health position peaked at $26.6M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.